Hardly anyone argues against financial incentives, but there is concern that badly designed programs will create a provider underclass.
Finally, it seems that there is a way to manage patients with multiple chronic conditions properly. Understanding and technology converge.
For more than a decade, it has seemed this would catch fire. But many insurers are still looking for evidence that it can reduce overall costs.
Thomas G. Dolan
The CMO of Blue Cross and Blue Shield of Minnesota is hopeful that the goal of true population management is near.
Although plans are not restructuring fee schedules in consumer-directed health plans, providers think their agreements need fine-tuning.
In response to the expense of new migraine therapies, treatment practices aimed at controlling direct costs are now the norm.
David W. Dodick, MD
Robert J. Lipsy, PharmD
Legislation & Regulation
Despite the focus on the international situation, Americans are still keenly interested in just how they'll get the medical care they need.
Sure, there may be some costs up front, but there is also an opportunity for health plans to profit as employers' concern about this issue grows.
When traditional therapies fail in cancer treatment, turning off a chemical switch may offer hope to the hopeless.
Thomas Morrow, MD
Managed Care Outlook